Sponsored by:
merck-ngs-adventitious-agent-testing-whitepaper-banner

Adventitious Agent Testing by NGS: A Comprehensive Solution with Targeted and Non-Targeted Methods

Discover how targeted and non-targeted Next-Generation Sequencing (NGS) methods support adventitious virus detection in cell banks

Discover how targeted and non-targeted Next-Generation Sequencing (NGS) methods support adventitious virus detection in cell banks, helping biopharmaceutical manufacturers strengthen viral safety testing and align with evolving regulatory expectations.

What You’ll Learn:

  • Broad-Spectrum Virus Detection: Understand how non-targeted NGS can detect known and unexpected viral contaminants without prior knowledge of a specific virus.
  • Targeted Virus Testing: Explore how the Blazar® Rodent Virus Panel uses targeted NGS (tNGS) to detect rodent-specific viruses.
  • Regulatory Alignment: Discover how NGS-based testing approaches align with ICH Q5A(R2) guidance and the principles of replacing, reducing, and refining animal use.
  • Automated Testing Workflows: Understand how automation supports consistent analysis, high-throughput testing, and faster turnaround times.

Why Choose NGS for Adventitious Agent Testing?

Traditional animal-based virus testing methods can present challenges in virus identification, variability, and turnaround time. Molecular approaches offer an alternative by detecting viral genetic material and providing information that can help identify potential contaminants.

Download Now